- Home
- CLPS vs NNVC Comparison
CLPS vs NNVC Comparison
Compare CLPS & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- NNVC
- Stock Information
- Founded
- CLPS 2005
- NNVC 2005
- Country
- CLPS Hong Kong
- NNVC United States
- Employees
- CLPS N/A
- NNVC N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- NNVC Health Care
- Exchange
- CLPS Nasdaq
- NNVC Nasdaq
- Market Cap
- CLPS 27.2M
- NNVC 22.5M
- IPO Year
- CLPS 2018
- NNVC N/A
- Fundamental
- Price
- CLPS $1.04
- NNVC $1.38
- Analyst Decision
- CLPS
- NNVC
- Analyst Count
- CLPS 0
- NNVC 0
- Target Price
- CLPS N/A
- NNVC N/A
- AVG Volume (30 Days)
- CLPS 7.8K
- NNVC 122.4K
- Earning Date
- CLPS 10-17-2025
- NNVC 09-26-2025
- Dividend Yield
- CLPS 12.18%
- NNVC N/A
- EPS Growth
- CLPS N/A
- NNVC N/A
- EPS
- CLPS N/A
- NNVC N/A
- Revenue
- CLPS $153,816,045.00
- NNVC N/A
- Revenue This Year
- CLPS N/A
- NNVC N/A
- Revenue Next Year
- CLPS N/A
- NNVC N/A
- P/E Ratio
- CLPS N/A
- NNVC N/A
- Revenue Growth
- CLPS 5.81
- NNVC N/A
- 52 Week Low
- CLPS $0.80
- NNVC $0.94
- 52 Week High
- CLPS $1.70
- NNVC $1.92
- Technical
- Relative Strength Index (RSI)
- CLPS 59.53
- NNVC 39.02
- Support Level
- CLPS $0.96
- NNVC $1.40
- Resistance Level
- CLPS $1.07
- NNVC $1.54
- Average True Range (ATR)
- CLPS 0.03
- NNVC 0.07
- MACD
- CLPS 0.01
- NNVC -0.01
- Stochastic Oscillator
- CLPS 81.25
- NNVC 15.43
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.